No Data
No Data
Maxim Group Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $3
Icecure Medical's Growth Potential Highlighted by Clinical Progress and Strategic Financial Position
H.C. Wainwright Maintains Icecure Medical(ICCM.US) With Buy Rating, Maintains Target Price $2.5
IceCure Medical Full Year 2024 Earnings: Misses Expectations
Express News | HC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $2.5 Price Target
Icecure Medical Analyst Ratings